Exhibit 99.2

CRANE CO.

Income Statement Data

(in millions, except per share data)

	Three Months Ended
	March 31,
		2016			2015
Net Sales:
Fluid Handling	$	248.0		$	275.6
Payment & Merchandising Technologies		172.0			171.9
Aerospace & Electronics		171.7			161.6
Engineered Materials		68.3			69.7
Total Net Sales	$	660.0		$	678.8
Operating Profit (Loss):
Fluid Handling	$	25.4		$	34.3
Payment & Merchandising Technologies		28.0			21.1
Aerospace & Electronics		33.1			30.1
Engineered Materials		13.7			14.3
Corporate		(14.7	)		(13.7	)
Total Operating Profit		85.5			86.0
Interest Income		0.5			0.5
Interest Expense		(9.1	)		(9.9	)
Miscellaneous - Net		(0.3	)		(0.3	)
Income Before Income Taxes		76.6			76.3
Provision for Income Taxes		21.4			24.9
Net income before allocation to noncontrolling interests		55.2			51.3
Less: Noncontrolling interest in subsidiaries' earnings		0.2			0.3
Net income attributable to common shareholders	$	55.0		$	51.1
Share Data:
Earnings per Diluted Share	$	0.93		$	0.87
Average Diluted Shares Outstanding		58.9			58.9
Average Basic Shares Outstanding		58.2			58.1
Supplemental Data:
Cost of Sales	$	426.1		$	440.0
Selling, General & Administrative		148.4			148.3
Repositioning Charges (see non-GAAP measures)		—			2.6
Acquisition Related Charges (see non-GAAP measures)		—			1.8
Depreciation and Amortization *		16.5			16.5
Stock-Based Compensation Expense *		6.1			5.8
* Amount included within Cost of Sales and Selling, General & Administrative costs.

1

CRANE CO.

Condensed Balance Sheets

(in millions)

	March 31, 2016		December 31, 2015
ASSETS
Current Assets
Cash and Cash Equivalents	$	354.0	$	363.5
Accounts Receivable, net	430.2		397.6
Current Insurance Receivable - Asbestos	20.5		20.5
Inventories, net	401.9		376.9
Other Current Assets	48.1		45.0
Total Current Assets	1,254.7		1,203.5
Property, Plant and Equipment, net	279.9		276.0
Long-Term Insurance Receivable - Asbestos	105.8		108.7
Other Assets	576.3		580.8
Goodwill	1,178.3		1,167.9
Total Assets	$	3,395.0	$	3,336.9
LIABILITIES AND EQUITY
Current Liabilities
Notes Payable and Current Maturities of Long-Term Debt	$	78.1	$	49.6
Accounts Payable	199.1		223.3
Current Asbestos Liability	75.0		75.0
Accrued Liabilities	213.5		218.6
Income Taxes	9.9		6.3
Total Current Liabilities	575.6		572.8
Long-Term Debt	744.8		744.6
Long-Term Deferred Tax Liability	52.0		50.0
Long-Term Asbestos Liability	456.8		470.5
Other Liabilities	340.9		348.1
Total Equity	1,224.9		1,150.8
Total Liabilities and Equity	$	3,395.0	$	3,336.9

2

CRANE CO.

Condensed Statements of Cash Flows

(in millions)

	Three Months Ended March 31,
	2016			2015
Operating Activities:
Net income attributable to common shareholders	$	55.0		$	51.1
Noncontrolling interest in subsidiaries' earnings	0.2			0.3
Net income before allocations to noncontrolling interests	55.2			51.3
Restructuring - Non Cash	—			0.2
Depreciation and amortization	16.5			16.5
Stock-based compensation expense	6.1			5.8
Defined benefit plans and postretirement expense	(2.4		)	(1.6		)
Deferred income taxes	5.3			4.3
Cash used for operating working capital	(82.0		)	(57.1		)
Defined benefit plans and postretirement contributions	(2.2		)	(3.0		)
Environmental payments, net of reimbursements	(2.0		)	(4.1		)
Other	(3.7		)	(13.4		)
Subtotal	(9.2		)	(0.9		)
Asbestos related payments, net of insurance recoveries	(10.8		)	(10.7		)
Total used for operating activities	(20.0		)	(11.6		)
Investing Activities:
Capital expenditures	(11.0		)	(10.2		)
Proceeds from disposition of capital assets	0.5			1.4
Total used for investing activities	(10.5		)	(8.8		)
Financing Activities:
Dividends paid	(19.2		)	(19.1		)
Reacquisition of shares on open market	—			(25.0		)
Stock options exercised - net of shares reacquired	0.6			6.7
Excess tax benefit from stock-based compensation	—			0.9
Repayment of credit facility	—			(100.0		)
Proceeds from issuance of commercial paper	28.5			126.7
Total provided by (used for) financing activities	9.9			(9.9		)
Effect of exchange rate on cash and cash equivalents	11.1			(19.0		)
Decrease in cash and cash equivalents	(9.5		)	(49.3		)
Cash and cash equivalents at beginning of period	363.5			346.3
Cash and cash equivalents at end of period	$	354.0		$	296.9

3

CRANE CO.

Order Backlog

(in millions)

	March 31, 2016		December 31, 2015		September 30, 2015		June 30, 2015		March 31, 2015
Fluid Handling	$	263.4	$	267.2	$	278.6	$	287.3	$	304.3
Payment & Merchandising Technologies	60.4		62.6		55.5		61.1		68.1
Aerospace & Electronics	418.7		436.4		459.9		448.1		446.1
Engineered Materials	16.0		15.2		13.7		15.4		18.6
Total Backlog	$	758.6	$	781.5	$	807.8	$	811.9	$	837.2

4

CRANE CO.

Non-GAAP Financial Measures

(in millions, except per share data)

	Three Months Ended March 31,						Percent Change March 31, 2016
	2016			2015			Three Months
INCOME ITEMS
Net Sales	$	660.0		$	678.8		(2.8	)%
Operating Profit	85.5			86.0			(0.6	)%
Percentage of Sales	13.0		%	12.7		%
Special Items impacting Operating Profit:
MEI acquisition related integration costs	—			1.6
MEI acquisition related restructuring costs	—			0.2
Repositioning charges	—			2.6
Operating Profit before Special Items	$	85.5		$	90.4		(5.4	)%
Percentage of Sales	13.0		%	13.3		%
Net Income Attributable to Common Shareholders	$	55.0		$	51.1
Per Share	$	0.93		$	0.87		7.8	%
Special Items impacting Net Income Attributable to Common Shareholders:
MEI acquisition related integration charges - Net of Tax	—			1.1
Per Share				$	0.02
MEI acquisition related restructuring charges - Net of Tax	—			0.1
Per Share				$	0.00
Repositioning charges - Net of Tax	—			1.8
Per Share				$	0.03
Net Income Attributable To Common Shareholders Before Special Items	$	55.0		$	54.1		1.8	%
Per Share	$	0.93		$	0.92		1.8	%

5

CRANE CO.

Guidance

(in millions)

	Three Months Ended March 31,						2016 Full Year Guidance
	2016			2015			Low			High
CASH FLOW ITEMS
Cash Provided by (Used for) Operating Activities
before Asbestos - Related Payments	$	(9.2	)	$	(0.9	)	$	290.0		$	320.0
Asbestos Related Payments, Net of Insurance Recoveries	(10.8		)	(10.7		)	(50.0		)	(50.0		)
Cash Provided by (Used for) Operating Activities	(20.0		)	(11.6		)	240.0			270.0
Less: Capital Expenditures	(11.0		)	(10.2		)	(50.0		)	(50.0		)
Free Cash Flow	$	(31.0	)	$	(21.8	)	$	190.0		$	220.0

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, management believes that non-GAAP financial measures which exclude certain non-recurring items present additional useful comparisons between current results and results in prior operating periods, providing investors with a clearer view of the underlying trends of the business. Management also uses these non-GAAP financial measures in making financial, operating, planning and compensation decisions and in evaluating the Company's performance.

In addition, Free Cash Flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate liquidity from its operating activities. The measure of Free Cash Flow does not take into consideration certain other non-discretionary cash requirements such as, for example, mandatory principal payments on the Company's long-term debt. Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.

6